Yasho Industries Ltd Q2 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/3x2a5lxxc8x89xzg2jofbccv.pdf

Key Takeaways


Demand & Macro Environment

Yayesh Jhaveri: "we haven't heard much of a recession in the Europe because our orders have not been impacted much on these. While in the US, still there is a slowdown, but there is no, we don't see or nor do they see any recession, recession coming in. So we are not seeing right now much of an impact, but maybe on days to come ahead, we might get a much clearer idea. And everything looks, till now we are cautious, but yes, but it looks pretty seasoned."

Product Mix & Margin Structure

Yayesh Jhaveri: "we do not have any long-term contracts with the customers at the moment because looking at today's scenario, nobody wants to commit for a longer future. So this is much more of a cushioning period for us, where we can increase, we can pass on our cost to our customers."

Competitive Position & China

Yayesh Jhaveri: "In a few chemicals which are more on the commodity side, yes, the prices of the Chinese materials are coming down, but not much on our specialty range. So we are very much cushioned by that because most of our specialty rubber chemicals we do not see much of a Chinese competition."

Greenfield Expansion: Pakhajan Project

Yayesh Jhaveri: "We already have the, it is just in the initial phase, we are only doing on the industrial products and the products that we are manufacturing currently. So it's just the capacity expansion, and we already have our customers shown us the desire to buy more product if we can deliver."

Balance Sheet & Capital Allocation


Guidance & Commitments

CommitmentSpecificsTimeline
FY23 revenue growth10% to 15% growth with continued margin and return improvementFY23
Phase I commercializationNew project at Pakhajan operationalAfter end of 2023 or early 2024
Phase I capacity utilizationAchieve ~60% utilization on new capacityBy 2024-2025
Peak revenue from expansionINR 1,250–1,300 crores at full 26,500-ton capacityAt full utilization (undated)
Working capital cycleMaintain at 95–100 daysOngoing
Product mix shiftContinue shifting toward industrial products to sustain marginsOngoing

Key Metrics

MetricQ2 FY23
Revenue₹192.4 cr, +40.2% YoY
Overseas revenue share>69% of total revenue
Industrial chemicals revenue share>80% of total revenue
Consumer chemicals revenue share~20% of total revenue
EBITDA margin18%, improved from 13% over the last 10 quarters
EBITDA margin (analyst reference)16% (analyst stated 16%; management did not confirm this figure)
FY23 revenue growth guidance10% to 15%
Phase I capacity addition15,500 MTPA, total capacity to reach ~26,500 MTPA
Phase I cash capex incurred (H1 FY23)₹64 cr
Peak revenue estimate at full capacity₹1,250–1,300 cr, implying additional ₹550–600 cr
Capex funding: bank loans₹240 cr
Capex funding: internal accruals₹110 cr
Total debt post capex~₹450 cr (per an analyst's math, which management acknowledged as approximately correct)
Working capital cycle95–100 days, currently ~100 days
Raw material inventory holding~2 months
New project commercialization timelineEnd of 2023 or early 2024
Products registered under REACH>40
Clients served2,000+
Permanent employees580+
Global country presence50+ countries